Cite

HARVARD Citation

    Atzori, M. et al. (2020). Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib. Journal of cellular and molecular medicine. 24 (1), pp. 465-475. [Online]. 
  
Back to record